Medicographia N° 118 (Vol 36 – N° 1 – 2014)

Stable coronary artery disease: an evolving picture

Coronary artery disease epidemics: not all the same
C. M. Reid, A. J. Owen, B. Freedman, Australia
The evolving clinical patterns of chronic coronary artery disease: clarifying the picture
P. G. Steg, France
Impact of stable coronary artery disease on quality of life: the patient’s perspective
M. Tendera, Poland
Rethinking the pathophysiology of stable coronary artery disease
A. Huqi, M. Marzilli, Italy
Pathophysiology and clinical significance of plaque rupture
G. Niccoli, F. Fracassi, F. Crea Italy
Evolving concepts in defining optimal strategies for the management of patients with stable ischemic heart disease
S. K. Padala, M. S. Sidhu, W. E. Boden, USA
Rethinking stent implantation for stable coronary artery disease
W. Wijns, Belgium
Heart rate and atherosclerotic plaque rupture: pathophysiological evidence and clinical perspectives
C. Gebhard, E. A. Kritikou, J. C. Tardif, Canada

Should stable CAD patients without angina receive anti-ischemic therapy?
M. Abdel Hamid, Egypt – S. Al-Saif, Saudi Arabia – E. Atalar, Turkey – L. M. Cesar, Brazil – G. H. Choo, Malaysia – X. Garcia-Moll, Spain – Y. Karpov, Russia – U. Laufs, Germany – N. Mewton, France – T. Q. Nguyen, Vietnam – A. N. Parkhomenko, Ukraine – R. Seabra-Gomes, Portugal – S. Y. Tan, Singapore – C. J. Vaughan, Ireland – P. H. Zelveian, Armenia

Clinical benefits of Procoralan (ivabradine): evidence and perspectives
I. Elyubaeva, France

SIGNIFY: hope for new perspectives in CAD management »
K. Fox, United Kingdom

Clinical perspectives in assessment of high-risk atherosclerotic plaques
R. Klingenberg, O. Gaemperli, T. F. Lüscher Switzerland

Taking Paris by storm: Benjamin Franklin, American Founding Father and first ambassador to France
T. J. Fleming, USA
Dr Benjamin Franklin’s scientific and medical legacy
J. V. Hirschmann, USA